NDT Pharmaceuticals Inc. (NDTP)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 25.16 Thousand | - | - | - | - | 1240.00 |
| Selling, General and Administrative Expenses | 25.16 Thousand | - | - | - | - | 1240.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 25.16 Thousand | - | - | - | - | 1240.00 |
| Operating Income | -25.17 Thousand | - | - | - | - | -1240.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -167.89 Thousand | - | - | - | - | - |
| Earnings before Tax | -79.03 Thousand | - | - | - | - | -1240.00 |
| Net Income | -79.03 Thousand | - | - | - | - | -1240.00 |
| Earnings Per Share Basic | -0.00 | - | - | - | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | - | - | - | -0.00 |
| Weighted Average Shares Outstanding | 160 Million | - | - | - | - | 302.45 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 160 Million | - | - | - | - | 302.45 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -79.02 Thousand | - | - | - | - | -1240.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2200.00 | 10.16 Thousand | 1520.00 | 25.16 Thousand | 2722.00 | 2057.00 |
| Selling, General and Administrative Expenses | 2200.00 | 10.16 Thousand | 1520.00 | - | 2722.00 | 2057.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2200.00 | 10.16 Thousand | 1520.00 | 25.16 Thousand | 2722.00 | 2057.00 |
| Operating Income | -2200.00 | -10.17 Thousand | -1520.00 | -25.17 Thousand | -2720.00 | -2060.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand |
| Earnings before Tax | -2200.00 | -10.16 Thousand | -1520.00 | -79.03 Thousand | -2722.00 | -2057.00 |
| Net Income | -2200.00 | -10.16 Thousand | -1520.00 | -79.03 Thousand | -2722.00 | -2057.00 |
| Earnings Per Share Basic | - | -0.00 | - | - | - | - |
| Earnings Per Share Diluted | - | -0.00 | - | - | - | - |
| Weighted Average Shares Outstanding | 160 Million | 160 Million | 160 Million | 160 Million | 160 Million | 160 Million |
| Weighted Average Shares Outstanding (Diluted) | 160 Million | 160 Million | 160 Million | 160 Million | 160 Million | 160 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2200.00 | -10.17 Thousand | -1520.00 | - | -2720.00 | -2060.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
9556
AZN
229000
PURI
9514
DUELL